Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis

Inclusion Criteria: * Patients having a stroke (ischemic and haemorrhagic) showing (one) subsequent seizure 14 days up to 3 years after stroke * Patients has signed the informed consent form * Aged ≥ 18 years Exclusion Criteria: * Severe stroke patients with Rankin scale \> 3 * Patients with a life expectancy of \< 12 months * Patients screened more than 15 days after first seizure * Patients with a diagnosed epilepsy * Patients with clear evidence of myoclonic seizures * Patients with contraindication to levetiracetam and carbamazepine use * Patients presenting epileptic status at onset * Patients having a MMSE \<24 * Patients having a seizure before stroke * Patients taking any AED 4 weeks prior to randomisation in the study * Patients showing dysphagia after stroke not able to swallow tablets. * Patients with a low compliance for the study * Pregnant women, lactating or sexually active women with childbearing potential who are not using a medically accepted birth control method. * Allergy or intolerance to pyrrolidine derivatives and/or tablet excipients or to carbamazepine derivates and /or tablet excipients * Patients involved in another clinical trial 30 days prior randomization * Patients with any tumour * Patients with previous traumatic brain accident resulting in impairment of consciousness. * Patients for whom it is not possible to assess seizure onset